OTUD7B and diffuse large B-cell lymphoma: OTUD7B is a prognostic maker in diffuse large B-cell lymphoma [30] and NSCLC [31], as well as a potential therapeutic target for myocardial infarction by ameliorating fibrosis [32], and predicts poor responses to paclitaxel in TNBC [28].